Porcine Segment has the Largest Share of Raw Material in the North America Extracellular Matrix Market during 2021–2028

According to our latest study on “North America Extracellular Matrix Market Forecast to 2028 – COVID-19 Impact and Analysis – by Raw Material, and Application,” the market is projected to reach US$ 20,111.6 Thousands by 2028 from US$ 12,163.1 Thousands in 2021; it is expected to grow at a CAGR of 7.4% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the significantly are increasing incidences of trauma and cardiovascular diseases and increasing vascular reconstruction procedures. However, challenges during the usage of decellularized extracellular matrix are expected to restrict the market growth during the forecast period.

The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for diagnosing and therapeutic devices have dramatically increased in the hospitals. For instance, the demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in hospitals across the countries in the region. The FDA has increased its efforts to support the health of people and has imposed several guidelines and for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing a growing number of COVID-19 cases since its outbreak.

Based on raw materials, the North America extracellular matrix market is bifurcated into bovine, porcine, and others. In 2021, the porcine segment is likely to account for the largest share of the market. However, the bovine segment is estimated to register the highest CAGR during the forecast period. Extracellular matrix made of porcine are derived from porcine adipose tissue, urinary bladder, or mammary fatty tissues. The most common parts of pigs such as skin and bones are used to derive extracellular matrix. The extracellular matrix derived from skin and bone are commonly used for the industrial purpose. Porcine collage is almost similar to human collagen, and it does not cause allergic response when used.

Medtronic, Merck Kgaa, Mtf Biologics, Smith & Nephew, Anteris, Aziyo, Coloplast Group, Baxter, DSM, and Cook Biotech are among the leading companies in the North America extracellular matrix market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for extracellular matrix market is segmented into raw material, and application. Based on raw material, the North America extracellular matrix market is segmented into bovine, porcine, and others. Based on application, the extracellular matrix market is segmented into soft tissue repair, dural repair, wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. Geographically, the extracellular matrix market is segmented into North America (US, Canada, Mexico).

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com